Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Henze

Showing results (61-70 of 231) with videos related to

Pageof 24
Sort By:
Klinische Padiatrie|May 1, 1981
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)]K Welte, U Ebener, L Hinderfeld, et al.
Medical and Pediatric Oncology|November 26, 1999
Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trialsK Seidemann, M Tiemann, G Henze, et al.
Haematology and Blood Transfusion|January 1, 1990
BFM group treatment results in relapsed childhood acute lymphoblastic leukemiaG Henze, R Fengler, R Hartmann, et al.
Pediatric Blood & Cancer|November 2, 2005
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcomaC Furth, H Amthauer, T Denecke, et al.
Onkologie|August 1, 1984
[Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group]S Müller-Weihrich, G Henze, H J Langermann, et al.
Progress in Clinical and Biological Research|January 1, 1983
Prognosis of acute lymphoblastic leukemia related to initial findings and treatmentG Henze, F Lampert, H J Langermann, et al.
Klinische Padiatrie|July 1, 1991
[Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]H Koch, L Schmitz, K Brockmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemiaC Wolfrom, R Hartmann, R Fengler, et al.
Bone Marrow Transplantation|November 1, 1996
Which children do benefit from bone marrow transplant? The EBMT Paediatric Diseases Working PartyD Niethammer, T Klingebiel, W Ebell, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1990
[Long-term experiences with central venous catheters in pediatric oncology]P Hadjilaskari, S Brühmüller, R Fengler, et al.
Pageof 24

Showing results (61-70 of 231) with videos related to

Sort By:
Pageof 24
Klinische Padiatrie|May 1, 1981
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)]K Welte, U Ebener, L Hinderfeld, et al.
Medical and Pediatric Oncology|November 26, 1999
Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trialsK Seidemann, M Tiemann, G Henze, et al.
Haematology and Blood Transfusion|January 1, 1990
BFM group treatment results in relapsed childhood acute lymphoblastic leukemiaG Henze, R Fengler, R Hartmann, et al.
Pediatric Blood & Cancer|November 2, 2005
Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcomaC Furth, H Amthauer, T Denecke, et al.
Onkologie|August 1, 1984
[Childhood B-cell lymphomas and leukemias. Improvement of prognosis by a therapy developed for B-neoplasms by the BFM study group]S Müller-Weihrich, G Henze, H J Langermann, et al.
Progress in Clinical and Biological Research|January 1, 1983
Prognosis of acute lymphoblastic leukemia related to initial findings and treatmentG Henze, F Lampert, H J Langermann, et al.
Klinische Padiatrie|July 1, 1991
[Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]H Koch, L Schmitz, K Brockmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemiaC Wolfrom, R Hartmann, R Fengler, et al.
Bone Marrow Transplantation|November 1, 1996
Which children do benefit from bone marrow transplant? The EBMT Paediatric Diseases Working PartyD Niethammer, T Klingebiel, W Ebell, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1990
[Long-term experiences with central venous catheters in pediatric oncology]P Hadjilaskari, S Brühmüller, R Fengler, et al.
Pageof 24